Genflow Biosciences plc (LON:GENF – Get Free Report) shares dropped 0.7% during mid-day trading on Tuesday. The company traded as low as GBX 1.61 and last traded at GBX 1.64. 214,823 shares were traded during trading, a decline of 90% from the average session volume of 2,128,509 shares. The stock had previously closed at GBX 1.65.
Genflow Biosciences Price Performance
The company has a fifty day moving average price of GBX 1.85 and a 200 day moving average price of GBX 2.01. The company has a market cap of £9.81 million, a PE ratio of -7.50 and a beta of 2.29.
Genflow Biosciences (LON:GENF – Get Free Report) last announced its earnings results on Tuesday, September 29th. The company reported GBX (0.08) earnings per share (EPS) for the quarter. Genflow Biosciences had a negative net margin of 187.87% and a positive return on equity of 609.63%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
See Also
- Five stocks we like better than Genflow Biosciences
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
